NCT05987397View on ClinicalTrials.gov

Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy

PHASE4RecruitingINTERVENTIONAL
Enrollment

2,700

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Post Stroke Epilepsy
Interventions
DRUG

idebenone 30 mg for 14 days

The patient received oral idebenone 30 mg three times a day after stroke for a total course of 14 days (acute phase).

DRUG

idebenone 30 mg for 3 months

The patient will be treated with oral idebenone 30 mg three times a day after stroke for a total course of 3 months.

Trial Locations (1)

410008

RECRUITING

Xiangya Hospital, Central South University, Changsha

All Listed Sponsors
lead

Xiangya Hospital of Central South University

OTHER